BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25363006)

  • 21. Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.
    Schroeder KM; Hoeman CM; Becher OJ
    Pediatr Res; 2014 Jan; 75(1-2):205-9. PubMed ID: 24192697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma.
    Sun Y; Sun Y; Yan K; Li Z; Xu C; Geng Y; Pan C; Chen X; Zhang L; Xi Q
    EBioMedicine; 2019 May; 43():171-179. PubMed ID: 31060906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric diffuse intrinsic pontine glioma: where do we stand?
    Rashed WM; Maher E; Adel M; Saber O; Zaghloul MS
    Cancer Metastasis Rev; 2019 Dec; 38(4):759-770. PubMed ID: 31802357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fifty years of DIPG: looking at the future with hope.
    Tosi U; Souweidane M
    Childs Nerv Syst; 2023 Oct; 39(10):2675-2686. PubMed ID: 37382660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interdisciplinary care of children with diffuse midline glioma.
    Coleman C; Chen K; Lu A; Seashore E; Stoller S; Davis T; Braunstein S; Gupta N; Mueller S
    Neoplasia; 2023 Jan; 35():100851. PubMed ID: 36410226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.
    Castel D; Philippe C; Calmon R; Le Dret L; Truffaux N; Boddaert N; Pagès M; Taylor KR; Saulnier P; Lacroix L; Mackay A; Jones C; Sainte-Rose C; Blauwblomme T; Andreiuolo F; Puget S; Grill J; Varlet P; Debily MA
    Acta Neuropathol; 2015 Dec; 130(6):815-27. PubMed ID: 26399631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
    Zhang L; Yu H; Xue Y; Liu Y
    Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.
    Bredlau AL; Dixit S; Chen C; Broome AM
    Curr Neuropharmacol; 2017; 15(1):104-115. PubMed ID: 26903150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brainstem glioma: a review.
    Grimm SA; Chamberlain MC
    Curr Neurol Neurosci Rep; 2013 May; 13(5):346. PubMed ID: 23512689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
    Hoffman LM; Veldhuijzen van Zanten SEM; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; von Bueren AO; Hargrave D; Solanki GA; Jadrijevic Cvrlje F; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; van Vuurden DG; Kramm CM; Fouladi M
    J Clin Oncol; 2018 Jul; 36(19):1963-1972. PubMed ID: 29746225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
    Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
    Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.
    Lober RM; Cho YJ; Tang Y; Barnes PD; Edwards MS; Vogel H; Fisher PG; Monje M; Yeom KW
    J Neurooncol; 2014 Mar; 117(1):175-82. PubMed ID: 24522717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving long-term survival in diffuse intrinsic pontine glioma.
    Felker J; Broniscer A
    Expert Rev Neurother; 2020 Jul; 20(7):647-658. PubMed ID: 32543245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
    Kline C; Jain P; Kilburn L; Bonner ER; Gupta N; Crawford JR; Banerjee A; Packer RJ; Villanueva-Meyer J; Luks T; Zhang Y; Kambhampati M; Zhang J; Yadavilli S; Zhang B; Gaonkar KS; Rokita JL; Kraya A; Kuhn J; Liang W; Byron S; Berens M; Molinaro A; Prados M; Resnick A; Waszak SM; Nazarian J; Mueller S
    Clin Cancer Res; 2022 Sep; 28(18):3965-3978. PubMed ID: 35852795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?
    Hargrave D
    CNS Oncol; 2012 Nov; 1(2):137-48. PubMed ID: 25057864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
    Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M
    Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pontine glioma.
    Dunkel IJ; Souweidane MM
    J Neurosurg Pediatr; 2009 Apr; 3(4):257; author reply 257-8. PubMed ID: 19338402
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.
    Rechberger JS; Lu VM; Zhang L; Power EA; Daniels DJ
    Childs Nerv Syst; 2020 Jan; 36(1):39-46. PubMed ID: 31489454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.